US Broker Ratings

Mind Medicine (MNMD) Stock Analysis: Exploring a 119% Potential Upside in the Biotech Arena

Investors with an eye for innovative healthcare solutions should take a closer look at Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneer in the biopharmaceutical industry..

Personalis, Inc. (PSNL) Stock Analysis: A 12% Potential Upside Amidst Diagnostic Innovation

Personalis, Inc. (NASDAQ: PSNL) is carving a niche in the diagnostics and research sector with its cutting-edge genomic tests and services aimed at revolutionizing cancer detection..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a 319.96% Upside Potential in Biotech Innovation

Tectonic Therapeutic, Inc. (NASDAQ: TECX) is emerging as a compelling investment opportunity within the biotechnology sector, particularly for those with an appetite for high-growth potential. With..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 32.91% Upside Potential in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising potential for growth in the biotechnology sector. With a market capitalization of..

Talkspace, Inc. (TALK) Stock Analysis: Unpacking the 47% Potential Upside for Investors

Talkspace, Inc. (NASDAQ: TALK) has been gaining traction in the healthcare sector, specifically within the burgeoning field of virtual behavioral health services. The company, which connects..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 45.60% Upside Potential in Biotech Innovation

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands at the forefront of the biotechnology sector, captivating investor attention with its promising clinical-stage developments and a potential upside of..

Castle Biosciences (CSTL) Stock Analysis: A Promising Play in Molecular Diagnostics with an 8.79% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a current market capitalization of approximately..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Understanding the 38.41% Potential Upside

For investors navigating the intricate landscape of biotechnology stocks, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) presents a compelling opportunity that warrants attention. Headquartered in San Diego,..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring the 108% Potential Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) has been making headlines in the biotech sector with its innovative approach to drug discovery and the remarkable potential upside of..

Xencor, Inc. (XNCR) Stock Analysis: Uncovering a 97.4% Potential Upside in Biotech Innovation

For investors seeking exposure in the healthcare sector, particularly in biotechnology, Xencor, Inc. (NASDAQ: XNCR) presents a compelling opportunity. With a market capitalization just shy of..

Geron Corporation (GERN) Stock Analysis: A Biotech Play with 235% Potential Upside

Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical firm, has recently caught the attention of investors, particularly due to its promising upside potential. With a market capitalization..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring a 30% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK), a biopharmaceutical company based in Bedford, Massachusetts, is making waves in the healthcare sector with its innovative approach to treating severe..

Cel-Sci Corporation (CVM) Stock Analysis: Biotechnology Innovator with 540% Potential Upside

For investors seeking high-risk, high-reward opportunities, Cel-Sci Corporation (NASDAQ: CVM) presents an intriguing proposition. This clinical-stage biotechnology company, headquartered in Vienna, Virginia, is currently valued at..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: 35% Potential Upside Sparks Investor Interest

Investors looking for opportunities in the healthcare sector may find Treace Medical Concepts, Inc. (NASDAQ: TMCI) a compelling option. With a current market capitalization of $393.57..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges in the Medical Devices Sector

Surmodics, Inc. (NASDAQ: SRDX), a notable player in the healthcare sector, specifically within the medical devices industry, is at a critical juncture that investors should watch..

Praxis Precision Medicines, Inc (PRAX): Stock Analysis Revealing 69.74% Potential Upside in the Biotech Sector

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a beacon in the biotechnology sector, has captivated investor attention with its robust pipeline focused on therapies for central nervous..

LifeMD, Inc. (LFMD): Analyst Ratings Signal a 144.77% Upside Potential for This Telehealth Innovator

LifeMD, Inc. (NASDAQ: LFMD) is making waves in the healthcare sector with its innovative approach to direct-to-patient telehealth services. As a company that bridges the gap..

Replimune Group, Inc. (REPL) Stock Analysis: Exploring a 38% Upside in the Biotech Sector

Replimune Group, Inc. (REPL) presents a compelling case for investors with an appetite for biotech innovation and growth potential. Specializing in oncolytic immunotherapies, Replimune is at..

Delcath Systems, Inc. (DCTH) Investor Outlook: Unveiling a Potential 172% Upside

Delcath Systems, Inc. (NASDAQ: DCTH), a pioneering entity in the healthcare sector, is drawing considerable attention from investors focused on medical devices. With a market capitalization..

HealthStream, Inc. (HSTM) Stock Analysis: Potential Upside of Over 37% Beckons Investors

HealthStream, Inc. (HSTM), a key player in the health information services industry, has been quietly charting a course for growth, making it a compelling consideration for..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds